All In Biotech

Drug Trial Radar · NCT00069641

Iduronate-2-sulfatase Enzyme Replacement Therapy in Mucopolysaccharidosis II (MPS II)

A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Weekly and Every Other Week Dosing Regimens of Iduronate-2-Sulfatase Enzyme Replacement Therapy in Patients With MPS II

Last checked: Nov 20, 2026Latest source record: Jun 10, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

96

Actual

Start

Sep 18, 2003

Primary completion

Mar 16, 2005

Study completion Mar 16, 2005

Sponsor

Lead sponsor
ShireTakeda (TAK)
Sponsor type
Industry
First posted
Oct 1, 2003

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
Male only, from 5 years, up to 25 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether the administration of iduronate-2-sulfatase enzyme in a weekly or every other week therapy frequency is safe and efficacious in patients with MPS II.

Conditions

  • Mucopolysaccharidosis II

Interventions

  • Iduronate-2-sulfatase enzyme replacement therapyBiological

    Patients will receive weekly infusions of idursulfase at a dose of 0.5 mg/kg.

  • iduronate-2-sulfatase enzyme replacement therapyBiological

    Patients will receive every other week infusions of idursulfase at a dose of 0.5 mg/kg.

  • PlaceboBiological

    Patients will receive weekly infusions of placebo.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Ranked Adjusted 2-Component Composite Variable Score Based on Change From Baseline to Week 53Time frame: Baseline, Week 53

Locations

9 sites in 4 countries. Site status is shown where the registry gives one.

  • Children's Hospital Oakland

    Oakland, California

  • St. Louis Children's Hospital, Washington University

    St Louis, Missouri

  • University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina

  • Texas Children's Hospital, Baylor College of Medicine

    Houston, Texas

  • Hospital de Clinicas de Porto Alegre

    Porto Alegre, Brazil

  • Children's Hospital, Johannes-Gutenburg Universitaet Mainz

    Mainz, Germany

  • Addenbrooke's Hospital

    Cambridge, England, United Kingdom

  • Great Ormond Street Hospital for Sick Children

    London, England, United Kingdom

  • Royal Manchester Children's Hospital

    Manchester, England, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.